John D. McConnell - Concepedia

Author

John D. McConnell

The University of Texas Southwestern Medical Center

Also Known As

J D McConnell, J McConnell, J. D. McConnell, J. McConnell, J.D. McCONNELL, J.D. McConnell, JOHN D. MCCONNELL, JOHN D. McCONNELL, JOHN McCONNELL, John D McConnell

157

Publications

12K

Citations

H-Index

100

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Merck & Co., Inc., Rahway, NJ, USA (United States)National Institute of Diabetes and Digestive and Kidney Diseases Johns Hopkins University

About

John D. McConnell is an author at The University of Texas Southwestern Medical Center specializing in medicine, urology, and urogynecology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	40	4.1K
2	Public Health	5	5	1.1K
3	Education	1	1	23
4	Health Sciences	1	1	26
5	Natural Sciences	1	1	96

John D. McConnell

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia John D. McConnell, Claus G. Roehrborn, Oliver Bautista, New England Journal of Medicine	2003	2K
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia Glenn J. Gormley, Elizabeth Stoner, Reginald C. Bruskewitz, New England Journal of Medicine	1992	1.1K
The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia John D. McConnell, Reginald C. Bruskewitz, Patrick Walsh, New England Journal of Medicine	1998	1.1K
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. Anice E. Thigpen, Richard I. Silver, Joseph M. Guileyardo, Journal of Clinical Investigation SpermatogenesisSteroid 5DermatologyReproductive BiologyAlpha-reductase Isozymes	1993	726
Detection and characterization of carcinoma cells in the blood Emilian Racila, David Euhus, Arthur J. Weiss, Proceedings of the National Academy of Sciences	1998	701
Relationship of Symptoms of Prostatism to Commonly Used Physiological and Anatomical Measures of the Severity of Benign Prostatic Hyperplasia Michael J. Barry, Abraham T.�K. Cockett, H. Logan Holtgrewe, The Journal of Urology Urological ResearchUrologyDisease SeverityOutcomes ResearchBenign Prostatic Hyperplasia	1993	411
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Claus G. Roehrborn, John D. McConnell, Michael M. Lieber, Urology Acute Urinary RetentionUrologyPowerful PredictorPathologyBenign Prostatic Hyperplasia	1999	336
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Riichiroh Maruyama, Shinichi Toyooka, Kiyomi O. Toyooka, PubMed	2002	326
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. John D. McConnell, J D Wilson, Fredrick W. George, The Journal of Clinical Endocrinology & Metabolism Testosterone ConcentrationMolecular PharmacologyUrologyAndrologyProstatic Dihydrotestosterone	1992	307
SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA Claus G. Roehrborn, John D. McConnell, JAIME BONILLA, The Journal of Urology	2000	266

Page 1